
Edopain ER600 mg
Incepta Pharmaceuticals Ltd.
Etodolac is a nonsteroidal anti-inflammatory drug (NSAID) that is FDA-approved for the following indications: Osteoarthritis (OA): Relief of the signs and symptoms of osteoarthritis and more.
Etodolac is a nonsteroidal anti-inflammatory drug (NSAID) that is FDA-approved for the following indications:
These are established, FDA-approved uses. Etodolac is not indicated for use in children for these conditions, and pediatric osteoarthritis/rheumatoid arthritis use in patients under 18 has not been demonstrated as safe and effective for this drug.
| Indication | Adult Dosage |
|---|---|
| Osteoarthritis / Rheumatoid arthritis (immediate-release) | 300 mg two or three times daily, or 400-500 mg twice daily; total daily dose generally not to exceed 1000 mg |
| Osteoarthritis / Rheumatoid arthritis (extended-release) | 400-1000 mg once daily, individualized to patient response |
| Acute pain | 200-400 mg every 6-8 hours as needed; total daily dose not to exceed 1000 mg (immediate-release only; extended-release is not indicated for acute pain) |
Etodolac should be taken with food, milk, or an antacid if gastrointestinal upset occurs, although this does not eliminate the risk of GI ulceration. The lowest effective dose should be used for the shortest duration consistent with individual treatment goals, in line with NSAID class safety recommendations. Extended-release tablets must be swallowed whole and must not be crushed, split, or chewed.
For dosing adjustment in hepatic or renal impairment, see Use in Special Populations.
Common side effects of Etodolac include:
Serious but less common adverse effects include gastrointestinal ulceration/bleeding/perforation, cardiovascular thrombotic events (myocardial infarction, stroke), hepatotoxicity, renal impairment, hypertension, heart failure exacerbation, severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis), and anaphylactoid reactions. Patients should seek prompt medical attention for signs of GI bleeding (black stools, vomiting blood), chest pain, shortness of breath, sudden weakness, or slurred speech while taking Etodolac.
Etodolac is contraindicated in the following situations:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.